Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 603Cyclophosphamide 547Magnetic Resonance Spectroscopy 527Radiotherapy 511Specimen Handling 505Nivolumab 412Cisplatin 380Carboplatin 371Blood Specimen Collection 304Biopsy 304Radiosurgery 287Paclitaxel 285Gemcitabine 272Surveys and Questionnaires 270Standard of Care 267fludarabine 265Dexamethasone 263Drug Therapy 262venetoclax 251Bevacizumab 249Oxaliplatin 210Capecitabine 202Rituximab 198Radiation 191Fluorouracil 191Ipilimumab 189durvalumab 185Doxorubicin 179Etoposide 177atezolizumab 169

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Thymalfasin × 1 year × Clear all
NCT06461910 2026-03-03

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06139419 2025-11-17

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

Sun Yat-sen University

Phase 2 Active not recruiting
114 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡